3347 BOLT 18-month analysis: efficacy and safety of sonidegib in patients with locally advanced basal cell carcinoma (laBCC) and evaluation of tumor response using 2 sets of composite assessment criteria. (September 2015) - Dummer, R.; Sondak, V.; Grichnik, J.; Schwartz, L.; Guminski, A.; Gutzmer, R.; Yi, T.; Trylesinski, A.; Sellami, D.; Migden, M.